Additional visit burden for universal influenza vaccination of US school-aged children and adolescents

Cynthia M Rand1, Peter G Szilagyi, Byung-Kwang Yoo

  • 1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA. cynthia_rand@urmc.rochester.edu

Insights

Universal influenza vaccination for US children requires millions of extra primary care visits. Even utilizing all existing appointments, most young patients need additional visits for flu shots, highlighting the need for efficient vaccination strategies.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Influenza vaccination is crucial for child and adolescent health.
  • Primary care settings are a key venue for childhood immunizations.
  • Estimating the impact of universal vaccination on primary care resources is essential.

Purpose of the Study:

  • To determine the number of additional primary care visits required for universal influenza vaccination of US children and adolescents.
  • To assess the feasibility of administering all influenza vaccinations within primary care settings.

Main Methods:

  • Cross-sectional study utilizing data from the 2003-2004 Medical Expenditure Panel Survey.
  • Analysis focused on children aged 5 to 18 years with a usual source of care.
  • Calculated the percentage of children needing additional visits based on different vaccination windows (3-, 4-, or 5-month periods).

Main Results:

  • A significant majority of children aged 5-18 would require 1-2 additional primary care visits for influenza vaccination.
  • Even when utilizing all available visits, substantial numbers of children would need extra appointments.
  • Nationally, an estimated 42 million additional visits could be necessary within a 5-month vaccination window.

Conclusions:

  • Universal influenza vaccination in primary care settings necessitates a considerable increase in patient visits.
  • Current primary care visit structures may be insufficient to accommodate universal influenza vaccination for all children and adolescents.
  • Development of efficient vaccination strategies is imperative for primary care practices to achieve universal influenza immunization goals.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...